Ketogenic Diet for New-Onset Absence Epilepsy

计划入组 40 人 · 首次发布于 2020 年 2 月 18 日

Flunarizine for Treatment Resistant Absence Epilepsy

计划入组 9 人 · 首次发布于 2023 年 12 月 1 日

BMB-101 in Absence Epilepsy and DEE

计划入组 20 人 · 首次发布于 2024 年 5 月 6 日

SRXXX (Epilepsy)

KCC1 inhibitor (epilepsy)

Epilepsy(Bit Bio)

EPILEPSY FOUNDATION OF AMERICA

United States

Korean Epilepsy Society

South Korea

Mid-Atlantic Epilepsy & Sleep Center, LLC

United States

Bright Minds Biosciences Advances BMB-101 for Drug-Resistant Epilepsy in Phase 2 Trial

Bright Minds Biosciences Initiates Phase 2 Trial of BMB-101 for Drug-Resistant Epilepsies

Bright Minds Biosciences Appoints Stephen Collins as Chief Medical Officer to Advance CNS Therapies